Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1998
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008952A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008936A1 Recombinant canine herpesvirus
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008603A1 Isolation of immunoglobulins
03/05/1998WO1998008548A2 Stable radioiodine conjugates and methods for their synthesis
03/05/1998WO1998008544A1 Alkaloid glycoside for use as a medicament
03/05/1998WO1998008543A1 Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008541A1 Inhibition of primary and/or secondary immune response to repeat adenoviral vector administration using cd40l specific antibodies
03/05/1998WO1998008540A1 Multivalent vaccine for clostridium botulinum neurotoxin
03/05/1998WO1998008539A1 Postinfection human immunodeficiency virus (hiv) vaccination therapy
03/05/1998WO1998008532A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998002552A3 Vaccine compositions
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998DE19636328A1 Use of human leukocyte antigen aggregates and/or antigen units
03/05/1998DE19634537A1 Medicament for treating allergies of the skin or mucous membrane
03/05/1998CA2296765A1 Soluble recombinant botulinum toxin proteins
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264244A1 Vaccine production of the bacillus anthracis protective antigen
03/05/1998CA2264177A1 Isolation of immunoglobulins
03/05/1998CA2263985A1 Stable radioiodine conjugates and methods for their synthesis
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826052A1 High molecular weight major outer membrane protein of moraxella
03/04/1998EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
03/04/1998EP0826050A1 Modified polypeptides for enhanced immunogenicity
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826006A1 Transeptithelial transport of molecular species
03/04/1998EP0826003A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/04/1998EP0826001A1 Acellular pertussis vaccines and methods of preparation thereof
03/04/1998EP0825998A1 Preparation of immunoglobulin
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825885A1 Pulmonary delivery of aerosolized medicaments
03/04/1998EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
03/04/1998EP0825874A1 Composition of tyrosine and polymerised allergen
03/04/1998EP0825873A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
03/04/1998EP0825870A1 Modulation of cytokine patterns of human autoreactive t-cell clones
03/04/1998EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/04/1998EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/04/1998EP0554389B1 Molecular clones of hiv-1 and uses thereof
03/04/1998EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines
03/04/1998EP0487632B1 Stabilized vaccine compositions
03/04/1998EP0390799B1 Respiratory syncytial virus: vaccines
03/04/1998CN1175264A Novel cyclodextrin-derivatives and method for the preparation thereof
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175262A Novel receptor
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1174742A Complex cow's milk gamma globulin and the making method thereof
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/03/1998US5723323 Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof
03/03/1998US5723314 Antigens and antibodies and peptides
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723309 Production of subunits of soluble T cell receptors by co-transfection
03/03/1998US5723299 Somatostatin receptors
03/03/1998US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering
03/03/1998US5723283 Immunology for mammals
03/03/1998US5723130 Adjuvants for vaccines against respiratory syncytial virus
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723128 Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
03/03/1998US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers
03/03/1998US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody
03/03/1998US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
03/03/1998US5723116 Decreased mortality of severe acute pancreatitis following proximal cytokine blockade
02/1998
02/26/1998WO1998008090A1 Anti-idiotypic antibodies to an epiglycanin
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007880A1 Human endokine alpha
02/26/1998WO1998007874A2 New systems for regulating genetic expression
02/26/1998WO1998007866A1 Antigenic protein originating in infectious laryngotracheitis virus
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007851A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007754A1 T1 receptor-like ligand ii
02/26/1998WO1998007753A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
02/26/1998WO1998007736A1 Don-1 gene and polypeptides and uses therefor
02/26/1998WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
02/26/1998WO1998007443A1 Microspheres containing immunogens, process for producing the same, and method for immunizing animals with the use of the same
1 ... 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 ... 1823